A galacturonan from Dioscorea opposita Thunb. regulates fecal and impairs IL-1 and IL-6 expression in diarrhea mice.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 131, doi. 10.1007/s10719-022-10053-z
- By:
- Publication type:
- Article
Works matching IS 02820080 AND DT 2022 AND VI 39 AND IP 1
Results: 10
1
2
Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 107, doi. 10.1007/s10719-022-10047-x
- By:
- Publication type:
- Article
3
Systemic deficiency of GM1 ganglioside in Parkinson's disease tissues and its relation to the disease etiology.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 75, doi. 10.1007/s10719-021-10025-9
- By:
- Publication type:
- Article
4
Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 55, doi. 10.1007/s10719-021-10024-w
- By:
- Publication type:
- Article
5
Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 39, doi. 10.1007/s10719-021-10023-x
- By:
- Publication type:
- Article
6
Novel insights on GM1 and Parkinson's disease: A critical review.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 27, doi. 10.1007/s10719-021-10019-7
- By:
- Publication type:
- Article
7
35 years in plant lectin research: a journey from basic science to applications in agriculture and medicine.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 83, doi. 10.1007/s10719-021-10015-x
- By:
- Publication type:
- Article
8
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 1, doi. 10.1007/s10719-021-10012-0
- By:
- Publication type:
- Article
9
Plasma membrane glycosphingolipid signaling: a turning point.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 99, doi. 10.1007/s10719-021-10008-w
- By:
- Publication type:
- Article
10
A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 13, doi. 10.1007/s10719-021-10002-2
- By:
- Publication type:
- Article